FSI Q1 2026 Earnings EPS Misses Estimates Stock Climbs 313 CRBP Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues Transdigm Group TDG Q1 2026 Earnings EPS Surpasses Estimates as Core Markets Remain Strong BORR Q1 2026 Earnings Significant EPS Miss and Stock Decline Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development LLY Q1 2026 Earnings Earnings Crush Drives Modest Stock Gains as Revenue Details Remain Limited